149 related articles for article (PubMed ID: 34463375)
1. Exploring the costs associated with isotretinoin treatment.
Shah N; Byrne M; Kirkorian AY
Pediatr Dermatol; 2021 Sep; 38(5):1396-1399. PubMed ID: 34463375
[TBL] [Abstract][Full Text] [Related]
2. Administrative Burden of iPLEDGE Deters Isotretinoin Prescriptions: Results From a Survey of Dermatologists.
Lee G; Wolf JR; Somers KE
Cutis; 2022 Jul; 110(1):44-47. PubMed ID: 36179224
[TBL] [Abstract][Full Text] [Related]
3. The future of iPLEDGE: We pledge for more inclusive access to isotretinoin.
Shah N; Kirkorian AY
Pediatr Dermatol; 2021 Nov; 38 Suppl 2():183-184. PubMed ID: 34184311
[No Abstract] [Full Text] [Related]
4. Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era.
Charrow A; Xia FD; Lu J; Waul M; Joyce C; Mostaghimi A
PLoS One; 2019; 14(3):e0210445. PubMed ID: 30913210
[TBL] [Abstract][Full Text] [Related]
5. Contraceptive counseling for iPLEDGE and its burden on dermatologists.
Owens KE; Jiang SW; Nicholas MW
Arch Dermatol Res; 2024 May; 316(6):287. PubMed ID: 38805059
[TBL] [Abstract][Full Text] [Related]
6. Circumventing iPLEDGE: Circumventing ethical responsibility?
Lee KC; Bercovitch L
J Am Acad Dermatol; 2017 Dec; 77(6):1185-1187. PubMed ID: 29132856
[No Abstract] [Full Text] [Related]
7. Can we ensure the safe use of known human teratogens?: The iPLEDGE test case.
Honein MA; Lindstrom JA; Kweder SL
Drug Saf; 2007; 30(1):5-15. PubMed ID: 17194167
[TBL] [Abstract][Full Text] [Related]
8. Simplifying contraception requirements for iPLEDGE: A decision analysis.
Barbieri JS; Roe AH; Mostaghimi A
J Am Acad Dermatol; 2020 Jul; 83(1):104-108. PubMed ID: 32068040
[TBL] [Abstract][Full Text] [Related]
9. Isotretinoin: update on controversial issues.
Prevost N; English JC
J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):290-3. PubMed ID: 24147278
[TBL] [Abstract][Full Text] [Related]
10. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
11. iPLEDGE Weaknesses: Is It Time to Address the Flaws?
Cyrulnik AA; Gewirtzman AJ; Paz KB; Glick JB; Anam AK; Carrasco DA; Shalita AR; Cohen SR
J Drugs Dermatol; 2016 Jan; 15(1):97-102. PubMed ID: 26741387
[TBL] [Abstract][Full Text] [Related]
12. Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States.
Pinheiro SP; Kang EM; Kim CY; Governale LA; Zhou EH; Hammad TA
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1251-7. PubMed ID: 23913625
[TBL] [Abstract][Full Text] [Related]
13. Isotretinoin, Patient Safety, and Patient-Centered Care-Time to Reform iPLEDGE.
Barbieri JS; Frieden IJ; Nagler AR
JAMA Dermatol; 2020 Jan; 156(1):21-22. PubMed ID: 31664426
[No Abstract] [Full Text] [Related]
14. Isotretinoin for acne and rosacea.
Watson KD; Miest RY; Tollefson MM
Semin Cutan Med Surg; 2016 Jun; 35(2):79-86. PubMed ID: 27416313
[TBL] [Abstract][Full Text] [Related]
15. Dietary Supplements, Isotretinoin, and Liver Toxicity in Adolescents: A Retrospective Case Series.
DeKlotz CMC; Roby KD; Friedlander SF
Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28864554
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients.
Shah N; Smith E; Kirkorian AY
J Am Acad Dermatol; 2021 Dec; 85(6):1597-1599. PubMed ID: 33259877
[No Abstract] [Full Text] [Related]
17. Gender differences in isotretinoin prescriptions during the COVID-19 pandemic at a U.S. academic medical center.
Duan GY; Ruiz de Luzuriaga AM
Arch Dermatol Res; 2023 Apr; 315(3):643-645. PubMed ID: 36149480
[TBL] [Abstract][Full Text] [Related]
18. Severe acne infantum successfully treated with isotretinoin.
Torrelo A; Pastor MA; Zambrano A
Pediatr Dermatol; 2005; 22(4):357-9. PubMed ID: 16060877
[TBL] [Abstract][Full Text] [Related]
19. Contradictory iPledge Requirements Hinder Physician Practice and Patient Care.
Pousti BT; Mollanazar NK
JAMA Dermatol; 2020 Feb; 156(2):222. PubMed ID: 31895417
[No Abstract] [Full Text] [Related]
20. Psychological impact of isotretinoin treatment in patients with moderate and severe acne.
Simić D; Situm M; Letica E; Penavić JZ; Zivković MV; Tomić T
Coll Antropol; 2009 Dec; 33 Suppl 2():15-9. PubMed ID: 20120397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
